Zhuzhou CRRC Times Electric Co Ltd (688187)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 46.28 |
|---|---|
| 52-week range | 43.15 – 67.65 |
| Return, 1 month / 3 months | +2.3% / −1.6% |
| Return, 1 year / 3 years | −7.0% / +14.0% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 45.4% |
| Worst drawdown (1 year) | -35.4% |
| Average daily value traded | 243.73M CNY |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zhuzhou CRRC Times Electric makes electrical equipment for rail transport. Its main products are propulsion and control systems for trains, including traction converters, inverters and auxiliary power supplies, along with electric drive equipment for locomotives, high-speed trains and urban transit vehicles. It also produces power semiconductor devices used in its own systems. The company is based in Zhuzhou, in Hunan province, China, and its customers are mainly railway operators and rolling stock builders, chiefly in the Chinese market.
The shares are listed on the Shanghai Stock Exchange in China under the code 688187, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zhuzhou CRRC Times Electric Co Ltd (688187) trades on the Shanghai Stock Exchange in China. It last closed at CNY 46.28 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 550 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.0% and over the last three months it fell 1.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.7% | ||
| From 52-week high | -31.0% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -7.5% | ||
| 12-month return, skipping the last month | -9.1% | ||
| Risk (lower is better) | 62 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 45.4% | ||
| Worst drawdown (1 year) | -35.4% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 243.73M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 92 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +2.3% |
| 3 months | −1.6% |
| 6 months | −7.5% |
| 1 year | −7.0% |
| 3 years | +14.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 46.53 / 51.27 |
|---|---|
| Golden / death cross (60 days) | Death, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | CNY 0.4600 |
| 7 Aug 2026 | CNY 0.6800 |
| 20 Oct 2025 | CNY 0.4400 |
| 8 Aug 2025 | CNY 1.0000 |
| 8 Aug 2024 | CNY 0.7800 |
| 8 Aug 2023 | CNY 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.